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Studies of the Expression of the
Cytochrome P4501A, P45011B, and P45011C
Gene Family in Extrahepatic and Hepatic
Tissues
by Thomas Friedberg,* Peter Siegert,* Markus A.
Grassow,* Barbara Bartlomowicz,* and Franz Oesch*
We have studied the expression ofthree P-450 gene subfamilies in hepatic and extrahepatic tissues using
the sensitive RNAse A protection assay. Members of the P4501A subfamily, which encodes the major
methylcholanthrene-inducible cytochromes P-450, were found to be not expressed in extrahepatic tissues
ofuntreatedanimals, raisingthequestion whetherthese P-450play arole inthemetabolism ofcarcinogens
in unexposed individuals. In contrast, members of the P45011B family, some of which encode the major
phenobarbital-inducible cytochromes P-450, were found to be expressed in some extrahepatic tissues of
untreated rats and here most notably in the lung and in sebaceous glands. Members ofthe P450IIC family,
which encode some constitutively expressed cytochromes P-450, were found to be expressed exclusively in
the liver.
Introduction
Cytochromes P-450 are a large family of monooxy-
genases that play an important role in the metabolism
of a wide variety of endogenous and exogenous com-
pounds including steroids and polycyclic hydrocarbons
(1). Recently several P-450 cDNAs and genomic clones
have been isolated and sequenced, making it possible
to order the various cytochrome P-450 genes in families
and subfamilies on the basis of sequence comparisons
(2,3).
Cytochromes P-450 have been mainly studied in the
liver, which is certainly not the target organ for most
chemical carcinogens. This approach has been chosen be-
cause the liver consists mainly of a single cell type, the
hepatocyte, and because this organ contains a consider-
able amount ofseveral cytochromes P450, some ofwhich
can be induced by xenobiotics. Only very few studies have
been concerned with cytochromes P450 in extrahepatic
tissues (4-6). In these studies antibodies against purified
cytochrome P450 isozymes have been used.
Onlyrecently specificoligomerprobes forcytochrome
P-450 genes have been used to study their expression
in several tissues (7). However, experiments involving
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oligonucleotides will only show whether a given probe
is able to recognize an mRNA, but will usually not re-
veal the extent ofrecognition. Thus, these methods are
not useful forthe identification ofapreviously unknown
member of a given cytochrome P-450 gene family. On
the other hand, Myers and Maniatis (8) have developed
amethod based onthe RNAse Aprotection assaywhich
willallowthedetection ofsinglepointmutations inlarge
stretches of the 3-globine gene. In this assay a radio-
labeled anti-sense RNA probe, which is generated in
vitro, is hybridized to RNA isolated from a tissue. The
resulting duplex molecules are treated with RNAse A,
which is known to cut into imperfectly matched duplex
molecules.
With this method we have studied the expression of
the P450IA family, which encodes the major methyl-
cholanthrene-inducible cytochromes P-450; the expres-
sion of the P450IIB family, which encodes the major
phenobarbital-inducible cytochromes P-450; and the
expression ofthe P450IIC family, which encodes some
cytochromes P-450 that are constitutively expressed in
several tissues.
Results
Tissue-Specific Expression of the P4501A
Family
The P450IA1 (1957-2620) transcript (numbers in pa-
renthesesindicatethe startandtheendofthetranscriptFRIEDBERG ET AL.
numbered from the initiation codon) was used for the
RNAse A protection assay with RNA isolated (9) from
several tissues (Fig. 1). The in vitro transcribed anti-
sense RNA (Fig. 1, lane 14) consisted mainly of a full
length transcript. RNA isolated from the liver of Ar-
oclor 1254-treated animals but not that from untreated
animals protected a large amount ofthe probe (Fig. 1,
lanes 1 and 2 vs. lane 3). RNA from the lung and the
kidney of Aroclor-treated animals protected consider-
ablyless RNAprobethandidhepaticRNAfromtreated
animals. Only a weak signal was obtained with RNA
from the intestinal mucosa of Aroclor-treated animals
(Fig. 1, lane 10). No signal was obtained with RNA
isolated from the kidney and the intestinal mucosa of
untreated animals nor with the RNA isolated from the
testis of untreated and treated rats nor from the brain
of male and female rats.
Tissue-Specific Expression of the P450IlB
Family
The P450IIB1 (133-499) anti-sense RNA was used in
the nuclease Si and RNAse A analysis ofRNA isolated
from several tissues. Nuclease Si protection assay of
mRNA from untreated animals and of Aroclor 1254-
treated animals (Fig. 2) yielded a protected fragment
which had the same size as the fragment generated in
the protection assay of the in vitro transcribed unla-
beled P450IIB1 (133-499) sense transcript (Fig. 2). As
expected, the amount ofthis fragment increased follow-
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FIGURE 1. Detection ofcytochromeP450IA RNAinvarioustissues.
The P450IA1 transcript was used in the protection assay with
RNA isolated from several tissues (lanes 1 and 2) liver of female
and male rat, respectively; (lane 3) liver of treated rat; (lane 4)
lung oftreated rat; (lanes 5 and 6) kidney ofuntreated and treated
rat, respectively; (lanes 7 and 8) testes of untreated and treated
rat, respectively; (lanes 9 and 10) intestinal mucosa of untreated
and treated rat, respectively; (lanes 11 and 12) brain ofmale and
female rat, respectively; (lane 13) no RNA added to assay; (lane
14) probe.
ing Aroclor treatment. The RNAse A protection assay
ofmRNAisolated from Aroclor-treated animalsyielded
anintense signalforafragmentthathad aslightlylower
size than the fragment seen in the nuclease Si protec-
tionassay(Fig. 2). Averysmallamountofthisfragment
was also seen in the RNAse protection assay ofmRNA
from control animals; however, this RNA yielded sev-
eral additional fragments that were hardly seen in the
analysis of mRNA isolated from Aroclor-treated ani-
mals (Fig. 2). This result clearly shows that the liver
of untreated animals contained a P450IIB1-related
mRNA that was suppressed by Aroclor treatment.
mRNA isolated from the lung and the intestine of
treated animals (Fig. 2) yielded the same RNAse A-
protectedfragmentastheinvitrotranscribed P450IIB1
(133-499) sense transcript. mRNA isolated from the
testis, thebrain, andthekidneydidnotgiveanydistinct
RNAse A- or nuclease Si-protected fragment. How-
ever, RNA isolated from the preputial gland yielded a
large amount of several partially RNAse A-protected
fragments that were distinct from the fragments ob-
tained in the analysis of RNA isolated from control an-
imals.
Tissue-Specific Expression of the P45011C
Family
Two probes were used to study the expression ofthe
genes of the P450IlC family. One probe was comple-
mentary to the P450IIC6 cDNA, the other probe was
complementary to the P450IIC7 cDNA. With the
P450IIC7 (613-763) probe, a signal was only obtained
with hepatic RNA from male and female rats, indepen-
dent ofwhether or not they had been treated with Aro-
clor 1254 (data not shown).
With the P450IIC6 (556-763) probe, two protected
fragments were only obtained with hepatic RNA from
untreated animals (Fig. 3). These protected fragments
were distinctly smaller than the fragment protected by
the in vitro transcribed P450IIC6 (556-763), indicating
that the probe hybridized to a hepatic RNA which was
not completely complementary to it.
Discussion
The P450IA family consists oftwo members, termed
P45OIA1 and P450IA2. These two genes appear to code
for two proteins that were named cytochrome P-450c
and d (10). Early immunological data ofGuengerich and
Mason (4) showed that these proteins occur in the liver
ofuntreated animals and are strongly induced by meth-
ylcholanthrene. In addition, these enzymes have been
found in several extrahepatic tissues. However, cyto-
chrome P45OIA1 and IA2 were not analyzed differen-
tially. In a recent study (5), the amount ofcytochrome
P45OIA1 protein was determined selectively in several
tissues. In contrast to our study (Fig. 1), P45OIA1 was
found to be expressed in control liver and kidney,
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FIGURE 2. Detection ofcytochrome P450IIB RNAs in various tissues. The P450IIB1 (133-499) anti-sense RNA probe was used in the nuclease
protection assays of various RNA samples. An asterisk below the lane number indicates that the assay was performed with nuclease Si.
Otherwise the assays were performed with RNAse A. The probe was incubated with the following RNA samples: (lanes 2 and 3) no RNA;
(lane 4) P450IIB1 (133-499) sense transcript, (lanes 5 and 6) hepatic RNA from untreated animals; (lanes 7, 8, 18, and 19) hepatic RNA
from Aroclor-treated animals; (lanes 9 and 10) lung RNA; (lanes 11 and 12) intestinal RNA; (lanes 13 and 14) testis RNA; (lanes 16 and 17)
brain RNA; (lanes 20 and 21) kidney RNA; (lanes 22 and 23) preputial gland RNA. The poly(A+) RNA from the lung, intestine, testis,
brain, kidney and preputial gland was isolated from Aroclor-treated animals, whereas the lung RNA was from untreated animals; 1.5 ,ug
of hepatic poly(A+) RNA from treated animals or 5 ,ug of poly(A+) RNA was used. The gel was subjected to autoradiography for 24 hr.
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FIGURE 3. Detection of cytochrome P450IIC6 RNA in various tis-
sues. The P450IIC6 transcript was used in the protection assay
with RNA isolated from several tissues (lane 1) probe; (lane 2)
liver; (lane 3) lung of treated animals; (lanes 4 and 5) kidney of
untreated and of treated animals, respectively; (lanes 6 and 7)
testes ofuntreated and treated animals, respectively; (lanes 8 and
9) intestinal mucosa of untreated and treated animals, respec-
tively; (lane 10) adrenal gland; (lane 11) brain of male animals;
(lane 12) brain of female animals; (lane 13) sense P450IIC6 tran-
script; (lane 14) anti-sense P450I1C6 transcript. In lanes 13 and
14 the indicated transcripts were incubated with the probe fol-
lowed by RNAse A treatment. Treatment was with Aroclor 1254.
Unless otherwise specified the tissues were from untreated ani-
mals.
methylcholanthrene-treated animals. By using a dilu-
tion series ofmRNA from treated animals, we estimate
that we should have detected a level ofP450IA1 mRNA
in the control liver and kidney, which is by a factor of
1000 lower than the level in the induced liver. Our data
are supported by a recent study- which found, using
oligomer probes, that only P450IA2, but not P450IA1,
is expressed in the liver of untreated animal (11).
In the study displayed in Figure 1, the signal con-
sisted of a fully protected fragment, and no distinct
partially protected fragments were obtained. However,
by using a probe covering the 5' end of the P450IA1
cDNA in the protection assay of RNA isolated from
treated animals instead of the P450IA1 (1957-2620)
probe, we detected shorter protected fragments in ad-
dition to the fully protected probe (data not shown).
Only these partially protected fragments were found in
the assay of mRNA isolated from untreated animals.
We think that the partially protected fragments were
derived from the P450IA2 RNA, indicating that only
P450IA2 and not P450IA1 is expressed in the liver of
untreated animals. Thus ourdatashow, usingthehighly
sensitive RNAse A protection assay, that besides the
liver, which expresses P450IA2, no other organ of un-
treated animals expresses P450IA genes. This obser-
vation raises the question whether the corresponding
proteins play a role in chemical carcinogenesis, which
seems unlikely unless one assumes that at least in hu-
mans those proteins are expressed due to exposure to
environmental compounds. On the other hand, our
study showed (Fig. 2) that members of the P450IIB
family, some ofwhich encode the major phenobarbital-
inducible cytochromes P-450, are expressed in the lung,
the liver, and the preputial gland ofuntreated animals.
However, for untreated animals, only RNA from the
lungyieldedaconsiderable amountofthefullyprotected
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P450IIB1 probe, whereas RNA from the liver and the
preputial gland, which is often used as a model for se-
baceous glands, yielded only partially protected frag-
ments, indicating that these organs do not express
P450IIB1, but other members of the P450IIB family.
Unlike the P450IA family, which appears to be ex-
pressed in some extrahepatic tissues of animals that
have been treated with the versatile cytochrome P-450-
inducer Aroclor 1254, and unlike the P4501IB family,
which appears to be expressed in some extrahepatic
tissues of untreated as well as treated animals, the
members of the P450IIC family were found to be ex-
pressed only in the liver (Fig. 3). Thus it appears that
the corresponding P450IlC proteins do not contribute
to the metabolism of carcinogens in extrahepatic tis-
sues.
From our study we conclude that members of the
P450IA family might play only a minor role in the ex-
trahepatic metabolism of carcinogens in untreated an-
imals but play an important role in the metabolism of
xenobiotics after exposure ofthe animals to compounds
such as Aroclor 1254. In contrast, some members ofthe
P450IIB family seem to be expressed constitutively in
some extrahepatic tissues such as the lung and may
contribute significantly to the metabolism ofxenobiotics
in those tissues.
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